Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)

0
175

Funding Opportunity ID: 325613
Opportunity Number: RFA-HG-20-014
Opportunity Title: Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.172
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Mar 19, 2020
Close Date: Jun 24, 2022
Last Updated Date: Mar 19, 2020
Award Ceiling: $700,000
Award Floor: $0
Estimated Total Program Funding:
Expected Number of Awards:
Description: This Funding Opportunity Announcement (FOA) solicits R01 grant applications to develop novel technologies that will enable no less than one order of magnitude improvement in synthetic nucleic acids. The goal is to improve the quality, capabilities and efficiency of nucleic acid synthesis and synthetic constructs (e.g., longer oligonucleotide and synthetic construct lengths, faster turn-around times, greater accuracy, incorporation of modified bases, higher-throughput, etc.) at reasonable and decreased costs with the anticipation that major advances in any of these and related areas would make significant contributions to the mission of NIH, NHGRI and the field of genomics, including to many of NHGRIs other technology development goals.
Version: 1





Visit the Official Webpage For More Details on Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)

LEAVE A REPLY

Please enter your comment!
Please enter your name here